2NT2 - Header Asymmetric Unit

HEADER HYDROLASE 06-NOV-06 2NT2

TITLE CRYSTAL STRUCTURE OF SLINGSHOT PHOSPHATASE 2

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN PHOSPHATASE SLINGSHOT HOMOLOG 2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 305-449; COMPND 5 SYNONYM: SLINGSHOT PHOSPHATASE 2, SSH-2L, HSSH-2L; COMPND 6 EC: 3.1.3.48, 3.1.3.16; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SSH2, KIAA1725, SSH2L; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A

KEYWDS ALPHA/BETA HYDROLASE

EXPDTA X-RAY DIFFRACTION

AUTHOR S.K.JUNG,D.G.JEONG,T.S.YOON,J.H.KIM,S.E.RYU,S.J.KIM

REVDAT 2 24-FEB-09 2NT2 1 VERSN REVDAT 1 05-JUN-07 2NT2 0

JRNL AUTH S.K.JUNG,D.G.JEONG,T.S.YOON,J.H.KIM,S.E.RYU,S.J.KIM JRNL TITL CRYSTAL STRUCTURE OF HUMAN SLINGSHOT PHOSPHATASE 2. JRNL REF PROTEINS V. 68 408 2007 JRNL REFN ISSN 0887-3585 JRNL PMID 17427953 JRNL DOI 10.1002/PROT.21399

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.144 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.144 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.174 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1128 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 22563 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3528 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 15 REMARK 3 SOLVENT ATOMS : 91 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.004 REMARK 3 ANGLE DISTANCES (A) : 1.370 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.348 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.048 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.021 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 2NT2 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-NOV-06. REMARK 100 THE RCSB ID CODE IS RCSB040266.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-OCT-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22566 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : 0.10000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.23500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1VHR REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL, PH 8.5, 25% PEG3350, REMARK 280 8% ETHANOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 25.84667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 12.92333 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS MONOMER

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 305 REMARK 465 ASP A 306 REMARK 465 ARG A 449 REMARK 465 MET B 305 REMARK 465 ASP B 306 REMARK 465 ARG B 449 REMARK 465 MET C 305 REMARK 465 ASP C 306 REMARK 465 ARG C 449

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TRP A 371 CA - CB - CG ANGL. DEV. = 15.7 DEGREES REMARK 500 TRP A 371 CB - CG - CD2 ANGL. DEV. = 8.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 335 -13.28 -140.08 REMARK 500 SER A 392 -145.84 -125.44 REMARK 500 SER A 397 -67.49 -123.38 REMARK 500 LYS A 430 80.64 -162.60 REMARK 500 VAL B 340 52.64 -91.24 REMARK 500 SER B 392 -142.76 -130.79 REMARK 500 SER B 397 -65.94 -129.56 REMARK 500 LYS B 430 82.53 -160.43 REMARK 500 VAL C 340 52.68 -94.53 REMARK 500 HIS C 384 30.99 -81.17 REMARK 500 SER C 392 -145.26 -133.74 REMARK 500 SER C 397 -75.96 -126.45 REMARK 500 LYS C 430 82.30 -167.25 REMARK 500 REMARK 500 REMARK: NULL

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 101 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 101 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 101

DBREF 2NT2 A 305 449 UNP Q76I76 SSH2_HUMAN 305 449 DBREF 2NT2 B 305 449 UNP Q76I76 SSH2_HUMAN 305 449 DBREF 2NT2 C 305 449 UNP Q76I76 SSH2_HUMAN 305 449

SEQADV 2NT2 SER A 392 UNP Q76I76 CYS 392 ENGINEERED SEQADV 2NT2 ARG A 449 UNP Q76I76 SER 449 VARIANT SEQADV 2NT2 SER B 392 UNP Q76I76 CYS 392 ENGINEERED SEQADV 2NT2 ARG B 449 UNP Q76I76 SER 449 VARIANT SEQADV 2NT2 SER C 392 UNP Q76I76 CYS 392 ENGINEERED SEQADV 2NT2 ARG C 449 UNP Q76I76 SER 449 VARIANT

SEQRES 1 A 145 MET ASP SER PRO THR GLN ILE PHE GLU HIS VAL PHE LEU SEQRES 2 A 145 GLY SER GLU TRP ASN ALA SER ASN LEU GLU ASP LEU GLN SEQRES 3 A 145 ASN ARG GLY VAL ARG TYR ILE LEU ASN VAL THR ARG GLU SEQRES 4 A 145 ILE ASP ASN PHE PHE PRO GLY VAL PHE GLU TYR HIS ASN SEQRES 5 A 145 ILE ARG VAL TYR ASP GLU GLU ALA THR ASP LEU LEU ALA SEQRES 6 A 145 TYR TRP ASN ASP THR TYR LYS PHE ILE SER LYS ALA LYS SEQRES 7 A 145 LYS HIS GLY SER LYS CYS LEU VAL HIS SER LYS MET GLY SEQRES 8 A 145 VAL SER ARG SER ALA SER THR VAL ILE ALA TYR ALA MET SEQRES 9 A 145 LYS GLU TYR GLY TRP ASN LEU ASP ARG ALA TYR ASP TYR SEQRES 10 A 145 VAL LYS GLU ARG ARG THR VAL THR LYS PRO ASN PRO SER SEQRES 11 A 145 PHE MET ARG GLN LEU GLU GLU TYR GLN GLY ILE LEU LEU SEQRES 12 A 145 ALA ARG SEQRES 1 B 145 MET ASP SER PRO THR GLN ILE PHE GLU HIS VAL PHE LEU SEQRES 2 B 145 GLY SER GLU TRP ASN ALA SER ASN LEU GLU ASP LEU GLN SEQRES 3 B 145 ASN ARG GLY VAL ARG TYR ILE LEU ASN VAL THR ARG GLU SEQRES 4 B 145 ILE ASP ASN PHE PHE PRO GLY VAL PHE GLU TYR HIS ASN SEQRES 5 B 145 ILE ARG VAL TYR ASP GLU GLU ALA THR ASP LEU LEU ALA SEQRES 6 B 145 TYR TRP ASN ASP THR TYR LYS PHE ILE SER LYS ALA LYS SEQRES 7 B 145 LYS HIS GLY SER LYS CYS LEU VAL HIS SER LYS MET GLY SEQRES 8 B 145 VAL SER ARG SER ALA SER THR VAL ILE ALA TYR ALA MET SEQRES 9 B 145 LYS GLU TYR GLY TRP ASN LEU ASP ARG ALA TYR ASP TYR SEQRES 10 B 145 VAL LYS GLU ARG ARG THR VAL THR LYS PRO ASN PRO SER SEQRES 11 B 145 PHE MET ARG GLN LEU GLU GLU TYR GLN GLY ILE LEU LEU SEQRES 12 B 145 ALA ARG SEQRES 1 C 145 MET ASP SER PRO THR GLN ILE PHE GLU HIS VAL PHE LEU SEQRES 2 C 145 GLY SER GLU TRP ASN ALA SER ASN LEU GLU ASP LEU GLN SEQRES 3 C 145 ASN ARG GLY VAL ARG TYR ILE LEU ASN VAL THR ARG GLU SEQRES 4 C 145 ILE ASP ASN PHE PHE PRO GLY VAL PHE GLU TYR HIS ASN SEQRES 5 C 145 ILE ARG VAL TYR ASP GLU GLU ALA THR ASP LEU LEU ALA SEQRES 6 C 145 TYR TRP ASN ASP THR TYR LYS PHE ILE SER LYS ALA LYS SEQRES 7 C 145 LYS HIS GLY SER LYS CYS LEU VAL HIS SER LYS MET GLY SEQRES 8 C 145 VAL SER ARG SER ALA SER THR VAL ILE ALA TYR ALA MET SEQRES 9 C 145 LYS GLU TYR GLY TRP ASN LEU ASP ARG ALA TYR ASP TYR SEQRES 10 C 145 VAL LYS GLU ARG ARG THR VAL THR LYS PRO ASN PRO SER SEQRES 11 C 145 PHE MET ARG GLN LEU GLU GLU TYR GLN GLY ILE LEU LEU SEQRES 12 C 145 ALA ARG

HET SO4 A 101 5 HET SO4 B 101 5 HET SO4 C 101 5

HETNAM SO4 SULFATE ION

FORMUL 4 SO4 3(O4 S 2-) FORMUL 7 HOH *91(H2 O)

HELIX 1 1 SER A 319 SER A 324 1 6 HELIX 2 2 ASN A 325 ARG A 332 1 8 HELIX 3 3 LEU A 367 ALA A 369 5 3 HELIX 4 4 TYR A 370 HIS A 384 1 15 HELIX 5 5 SER A 397 GLY A 412 1 16 HELIX 6 6 ASN A 414 ARG A 426 1 13 HELIX 7 7 ASN A 432 ALA A 448 1 17 HELIX 8 8 SER B 319 SER B 324 1 6 HELIX 9 9 ASN B 325 GLY B 333 1 9 HELIX 10 10 LEU B 367 ALA B 369 5 3 HELIX 11 11 TYR B 370 HIS B 384 1 15 HELIX 12 12 SER B 397 GLY B 412 1 16 HELIX 13 13 ASN B 414 ARG B 426 1 13 HELIX 14 14 ASN B 432 ALA B 448 1 17 HELIX 15 15 SER C 319 SER C 324 1 6 HELIX 16 16 ASN C 325 GLY C 333 1 9 HELIX 17 17 LEU C 367 ALA C 369 5 3 HELIX 18 18 TYR C 370 HIS C 384 1 15 HELIX 19 19 SER C 397 GLY C 412 1 16 HELIX 20 20 ASN C 414 ARG C 426 1 13 HELIX 21 21 ASN C 432 ALA C 448 1 17

SHEET 1 A 5 THR A 309 PHE A 312 0 SHEET 2 A 5 VAL A 315 GLY A 318 -1 O LEU A 317 N THR A 309 SHEET 3 A 5 LYS A 387 HIS A 391 1 O VAL A 390 N PHE A 316 SHEET 4 A 5 VAL A 334 ASN A 339 1 N LEU A 338 O HIS A 391 SHEET 5 A 5 GLU A 353 ASN A 356 1 O GLU A 353 N ILE A 337 SHEET 1 B 5 THR B 309 PHE B 312 0 SHEET 2 B 5 VAL B 315 GLY B 318 -1 O LEU B 317 N THR B 309 SHEET 3 B 5 LYS B 387 HIS B 391 1 O VAL B 390 N PHE B 316 SHEET 4 B 5 VAL B 334 ASN B 339 1 N TYR B 336 O LEU B 389 SHEET 5 B 5 GLU B 353 ASN B 356 1 O GLU B 353 N ILE B 337 SHEET 1 C 5 THR C 309 PHE C 312 0 SHEET 2 C 5 VAL C 315 GLY C 318 -1 O VAL C 315 N ILE C 311 SHEET 3 C 5 LYS C 387 HIS C 391 1 O VAL C 390 N PHE C 316 SHEET 4 C 5 VAL C 334 ASN C 339 1 N LEU C 338 O LEU C 389 SHEET 5 C 5 GLU C 353 ASN C 356 1 O HIS C 355 N ASN C 339

SITE 1 AC1 8 ASP A 361 SER A 392 LYS A 393 MET A 394 SITE 2 AC1 8 GLY A 395 VAL A 396 SER A 397 ARG A 398 SITE 1 AC2 8 ASP B 361 SER B 392 LYS B 393 MET B 394 SITE 2 AC2 8 GLY B 395 VAL B 396 SER B 397 ARG B 398 SITE 1 AC3 9 HOH C 66 ASP C 361 SER C 392 LYS C 393 SITE 2 AC3 9 MET C 394 GLY C 395 VAL C 396 SER C 397 SITE 3 AC3 9 ARG C 398

CRYST1 94.580 94.580 38.770 90.00 90.00 120.00 P 32 9

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.010573 0.006104 0.000000 0.00000

SCALE2 0.000000 0.012209 0.000000 0.00000

SCALE3 0.000000 0.000000 0.025793 0.00000